ARTICLE | Clinical News
GI262570: Phase III trial update
July 10, 2000 7:00 AM UTC
Glaxo Wellcome plc (LSE:GLXO; GLX), London, U.K. SmithKline Beecham plc (LSE:SB; SBH), London, U.K. Product: GI262570 Business: Pharmaceuticals Therapeutic category: Receptor agonist Target: Peroxiso...